APA

Koh A., Lee W. K., Chen L., Chen S., Hashad Y., Kim H., Lai T. Y., Pilz S., Ruamviboonsuk P., Tokaji E., Weisberger A. & Lim T. H. (20121128). EVEREST study: efficacy and safety of verteporfin photodynamic therapy in combination with ranibizumab or alone versus ranibizumab monotherapy in patients with symptomatic macular polypoidal choroidal vasculopathy. : Retina (Philadelphia, Pa.).

Chicago

Koh Adrian, Lee Won Ki, Chen Lee-Jen, Chen Shih-Jen, Hashad Yehia, Kim Hakyoung, Lai Timothy Y, Pilz Stefan, Ruamviboonsuk Paisan, Tokaji Erika, Weisberger Annemarie and Lim Tock H. 20121128. EVEREST study: efficacy and safety of verteporfin photodynamic therapy in combination with ranibizumab or alone versus ranibizumab monotherapy in patients with symptomatic macular polypoidal choroidal vasculopathy. : Retina (Philadelphia, Pa.).

Harvard

Koh A., Lee W. K., Chen L., Chen S., Hashad Y., Kim H., Lai T. Y., Pilz S., Ruamviboonsuk P., Tokaji E., Weisberger A. and Lim T. H. (20121128). EVEREST study: efficacy and safety of verteporfin photodynamic therapy in combination with ranibizumab or alone versus ranibizumab monotherapy in patients with symptomatic macular polypoidal choroidal vasculopathy. : Retina (Philadelphia, Pa.).

MLA

Koh Adrian, Lee Won Ki, Chen Lee-Jen, Chen Shih-Jen, Hashad Yehia, Kim Hakyoung, Lai Timothy Y, Pilz Stefan, Ruamviboonsuk Paisan, Tokaji Erika, Weisberger Annemarie and Lim Tock H. EVEREST study: efficacy and safety of verteporfin photodynamic therapy in combination with ranibizumab or alone versus ranibizumab monotherapy in patients with symptomatic macular polypoidal choroidal vasculopathy. : Retina (Philadelphia, Pa.). 20121128.